Elite Pharmaceuticals Inc (ELTP)

[namtae]

ELTP wont benefit from Isradipine approval for PD?

Here's the case being made:

I do not think Elite Pharmaceuticals has ever said anything. The hype is that ELTP would benefit from isradipine for parkinson's research.

According to parkinson-study-group.org homepage, "The PSG has partnered with numerous pharmaceutical companies and the National Institutes of Health (NIH) in bringing new drugs for Parkinson disease to the market including pramipexole, entacapone, rotigotine and rasagiline." Those are expensive drugs called Mirapex, Comtan, Neupro, and Azilect.

Isradipine for parkinson would most likely be manufactured and marketed, under a brand name, by a pharmaceutical. That is probably years away, assuming it works. Don't you need two Phase 3 studies to file an NDA?

Also, isradipine for parkinson has a pending patent by the inventor. I assume the patent holder would license it to some pharmaceutical to gain financially from the research.